THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR FILOVIRUSES INCLUDING EBOLAVIRUS AND MARBURG VIRUS

Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use

LONE STAR VIRUS

Antiviral agent against animal viruses

Biological therapeutics for infection-relating disorders or conditions

Identification of antibodies specific for at least two different lyssaviruses

Monoclonal antibodies that neutralize a norovirus

Methods of generating robust passive and active immune responses

Norovirus vaccine formulations

Methods for producing antibodies

Full spectrum anti-dengue antibody

Monoclonal antibodies for Ebola and Marburg viruses

Human antibodies to middle east respiratory syndrome—coronavirus spike protein

Dengue virus vaccine composition

HUMAN ANTIBODIES AGAINST RABIES AND USES THEREOF

Porcine epidemic diarrhea virus vaccine

Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl peptidase as its virus receptor

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

Monoclonal antibodies for Ebola and Marburg viruses

Human Ebola virus species and compositions and methods thereof

Cross-reactive antibodies against dengue virus and uses thereof

Arterivirus protein and expression mechanisms

BINDING MOLECULES TARGETING PATHOGENS

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

Compositions and methods related to the prevention and treatment of rabies infection

Infectious bursal disease (IBDV) vaccine compositions

Pathogenic phlebovirus isolates and compositions and methods of use

Human rotavirus vaccine strains and diagnostics

Compositions and methods for preventing or relieving symptoms of infections

Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics

Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof

SOLUBLE AND MEMBRANE-ANCHORED FORMS OF LASSA VIRUS SUBUNIT PROTEINS

Anti-human respiratory syncytial virus (RSV) antibodies and methods of use

Therapy for filovirus infection

Anti-human norovirus GII antibody

Norovirus vaccine formulations

Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use

Lentiviral gene transfer vectors and their medicinal applications

B cell lineage based immunogen design with humanized animals

Rift Valley Fever Virus glycoproteins, Gn and Gc, and their use

Methods of murine astrovirus detection

Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, composition, and treatment methods for rotavirus infections

HCV genotype 6 replicons

NOVEL NON-PRIMATE HEPACIVIRUS

Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration

Ultralong complementarity determining regions and uses thereof

THERMOSTABLE ANTIBODY FRAMEWORK REGIONS

Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof

Anti-dengue virus antibodies and uses thereof

ULTRALONG COMPLEMENTARITY DETERMINING REGIONS AND USES THEREOF

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

Monoclonal antibody production by EBV transformation of B cells

Stabilized liquid egg material for extended shelf life

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

Norovirus vaccine formulations

Norovirus vaccine formulations

Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof

Identification of antibodies specific for lyssaviruses and methods of their use

Rotavirus subunit vaccines and methods of making and use thereof

Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth

HEMORRHAGIC FELINE CALICIVIRUS, CALICIVIRUS AND METHOD FOR PREVENTING CALICIVIRUS INFECTION OR DISEASE

Anti-human respiratory syncytial virus (RSV) antibodies and methods of use

MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINS

MONOCLONAL ANTIBODIES THAT BIND OR NEUTRALIZE DENGUE VIRUS

Cluster of Neutralizing Antibodies to Hepatitis C Virus

Piscine reovirus diagnostic compositions

Piscine reovirus immunogenic compositions

Methods and compositions related to glycoprotein-immunoglobulin fusions

HUMAN ANTIBODIES AGAINST RABIES AND USES THEREOF

Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide

Lentiviral gene transfer vectors and their medicinal applications

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

Monoclonal antibodies for Ebola and Marburg viruses

Human Ebola Virus Species and Compositions and Methods Thereof

Viral diagnostics

Method for selecting a single cell expressing a heterogeneous combination of antibodies

Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus

Norovirus vaccine formulations

SRSV detection kit

Heavy Chain and Domain Antibodies

Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications

Human rotavirus vaccine strains and diagnostics

Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences

PRRS-VIRUS RECEPTOR AND ITS INHIBITOR

NOROVIRUS VACCINE FORMULATIONS

Mixtures of binding proteins

Tag peptide having a protease recognition sequence and use thereof

VACCINE

MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS

Single Chain Antibody for the Detection of Noroviruses

Antibodies for Norovirus

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing development of calicivirus disease

Method for production of antibody using ostrich

Method of producing anti-CD166 antibody in ostrich

ANTIVIRAL AGENT AGAINST ANIMAL VIRUSES

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

Coronavirus S Peptides

Recombinant production of mixtures of antibodies

Stabilized liquid egg material for extended shelf life

CROSS-NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES TO SARS-CoV AND METHODS OF USE THEREOF

Compositions Comprising Antibodies or Antibody Fragments

Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use

Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics

Methods and reagents for diagnosing hantavirus infection

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

Methods for determining the presence of antibodies blocking viral infection

Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use

RABIES CURE

Human antibodies against rabies and uses thereof

Monoclonal antibodies that bind or neutralize dengue virus

Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections

Puumala virus full-length M segment-based DNA vaccines

VIRAL VACCINE VECTORS

PAPAYA MOSAIC VIRUS-BASED VACCINES AGAINST SALMONELLA TYPHI AND OTHER ENTEROBACTERIAL PATHOGENS

Binding molecules capable of neutralizing rabies virus and uses thereof

Lentiviral gene transfer vectors and their medicinal applications

SELECTION OF HUMAN MONOCLONAL ANTIBODIES BY MAMMALIAN CELL DISPLAY

Activation of natural killer (NK) cells and methods of use

Binding molecules capable of neutralizing rabies virus and uses thereof

SOLUBLE AND MEMBRANE ANCHORED FORMS OF LASSA VIRUS SUBUNIT PROTEINS

Vaccine compositions and methods containing an immunogen derived from equine arteritis virus

VACCINE

Antibodies for norovirus

PEPTIDES, ANTIBODIES AND FRAGMENTS THEREOF FOR THE TREATMENT AND DIAGNOSTIC OF CELIAC DISEASE

METHODS AND COMPOSITIONS IN THE TREATMENT OF PORCINE CIRCOVIRAL INFECTION

Binding molecules against SARS-coronavirus and uses thereof

Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits

Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits

PRODUCTS FOR PROPHYLAXIS AND/OR TREATMENT OF VIRAL DISEASES AND METHODS OF MAKING AND USING SAME

Human rotavirus and vaccine composition comprising same

Liquid anti-rabies antibody formulations

Monoclonal antibody production by EBV transformation of B cells

Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof

ANTIBODY PRODUCED USING OSTRICH AND METHOD FOR PRODUCTION THEREOF

SRSV detection kit

Soluble Fragments of The Sars-Cov Spike Glycoprotein

METHOD FOR MEASUREMENT OF SARS VIRUS NUCLEOCAPSID PROTEIN, REAGENT KIT FOR THE MEASUREMENT, TEST DEVICE, MONOCLONAL ANTIBODY DIRECTED AGAINST SARS VIRUS NUCLEOCAPSID PROTEIN, AND HYBRIDOMA CAPABLE OF PRODUCING THE MONOCLONAL ANTIBODY

Monoclonal antibody to the common epitope of NSs protein of watermelon silver mottle virus and assay for tospovirus

Process for the production of monoclonal antibodies

Recombinant production of mixtures of antibodies

Food Products Comprising Probiotic Micro-Organisms and Antibodies

Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences

Composition

HN epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope

IMMUNOPEPTIDES OF HPV E6 AND E7 PROTEINS

REPLIKIN PEPTIDES AND USES THEREOF

Human antibodies against rabies and uses thereof

Norovirus vaccine formulations

Norovirus detection, methods and compositions therefor

Anti-Sars Virus Antibody, Hybridoma Producing the Antibody and Immunoassay Reagent Using the Antibody

Antibodies to SARS coronavirus

Treatment of Diseases

Binding molecules capable of neutralizing rabies virus and uses thereof

Heavy chain and single domain antibodies

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease

Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits

Methods and reagents for diagnosing hantavirus infection

Anti-SARS monoclonal antibodies

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

Binding molecules capable of neutralizing rabies virus and uses thereof

Compositions against SARS-coronavirus and uses thereof

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

Mutant G Genes of the Trout Viral Haemorrhagic Septicaemia Virus (Vhsv) and Applications Thereof

METHOD AND COMPOSITION FOR CONFERRING IMMUNITY IN MAMMALS

Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with SARS corona virus spike protein

Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses

Bivalent IgY antibody constructs for diagnostic and therapeutic applications

Monoclonal antibodies that bind or neutralize dengue virus

Antigenic peptides of SARS coronavirus and uses thereof

Sars coronavirus s proteins and uses thereof

Diagnostics for sars virus

Recombinant production of mixtures of antibodies

Binding molecules capable of neutralizing rabies virus and uses thereof

Mixture of binding proteins

Recombinant production of mixtures of antibodies

Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines

Compositions and methods for generating an immune response

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

Proteins encoded by the severe acute respiratory syndrome (SARS) coronavirus and a role in apoptosis

Antigenic peptides of rabies virus and uses thereof

Severe acute respiratory syndrome coronavirus

Methods for producing Marburg virus proteins

Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus

Soluble fragments of the SARS-CoV spike glycoprotein

Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof

Recombinant antibodies and compositions and methods for making and using the same

Coronavirus S peptides

SRSV detection kit

Method for selecting a single cell expressing a heterogeneous combination of antibodies

Prevention and treatment of the porcine reproductive and respiratory syndrome (PRRS)

Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain

Production of rabies antibodies in plants

Antigen delivery platform

Binding molecules against SARS-coronavirus and uses thereof

Antigenic peptides of SARS coronavirus and uses thereof

Porcine reproductive and respiratory syndrome virus receptor components and uses thereof

Activation of natural killer (NK) cells and methods of use

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease

Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses

DNA expression vectors and methods of use

Feline infectious peritonitis (FIP) and systemic multi-organ coronavirus biomarkers and screening methods

Bifunctional molecules

Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics

RNA virus expression and replication, methods and uses therefor

Methods and compositions for use in the treatment of filovirus mediated disease conditions

Antibodies against SARS-CoV and methods of use thereof

Recombinant vesiculoviruses and their uses

Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

Immunoglobulins and method for their modification

Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays

Kits for detecting anti-SIRS antibodies

Replikin peptides and uses thereof

Corona-virus-like particles comprising functionally deleted genomes

Recombinant production of mixtures of antibodies

Monoclonal antibodies and their use

Norovirus monoclonal antibodies and peptides

Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS)

Epitope profiles of SARS coronavirus

Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)

Equine arteritis virus vaccine

SARS nucleic acids, proteins, antibodies, and uses thereof

Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits

Compositions for regulating production of an antibody like protein and ribonucleic acid

Multivalent anti-SARS-CoV-2 nanobodies

SARS-CoV-2 variant nanobodies and constructs comprising such nanobodies

Compositions for targeting SARS-CoV-2 spike protein receptor binding domain

Antibody binding detection method for detecting MERS-CoV

Expression vector for anti-SARS-CoV-2 neutralizing antibodies

Shark VNARs for treating COVID-19

Coronavirus neutralizing humanized antibodies and uses thereof

Rapid assay for detection of SARS-CoV-2 antibodies

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

Pathogen specific avian antibodies in the neonatal mammal